Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.

Completed

• Conditions: Polytrauma; Red Blood Cell Distribution Width; Comorbidities and Coexisting Conditions
• Interventions: Other: retrospective

• Registration Number: NCT05221476
• Lead Sponsor: Medical University of Vienna

Brief Summary

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS\>16 points, an AIS \>3 in one body region and at least 2 different body regions affected were included. RDW values on admission as well as preexisting comorbidities were evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Study First Submitted: 2022-01-08
• Study First Submitted QC: 2022-01-21
• Study First Posted: 2022-02-03
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-22
• Last Update Posted: 2024-11-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• ISS >16 points
• AIS >3 in one body region
• at least 2 body regions affected

Read More

Exclusion Criteria

• patients younger than 18 years of age
• isolated traumatic brain injury
• minor injuries (AIS <3 or ISS <16 points)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
polytraumatized patients	retrospective	Patients with an ISS \>16 points, an AIS \>3 in one body region and at least 2 different body regions affected were included.

Primary Outcome Measures

Name	Time	Method
In-hospital mortality in polytraumatized patients	January 2012 to December 2015

Secondary Outcome Measures

Name	Time	Method
Possible influence of RDW values (%) on admission on the long-term outcome	January 2012 to December 2015	The influence of RDW Values (%) in polytraumatized patients on admission on the long-term outcome (late-phase death (days)) will be examined.